1. Home
  2. LDP vs VALN Comparison

LDP vs VALN Comparison

Compare LDP & VALN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Cohen & Steers Limited Duration Preferred and Income Fund Inc.

LDP

Cohen & Steers Limited Duration Preferred and Income Fund Inc.

HOLD

Current Price

$20.70

Market Cap

606.3M

Sector

Finance

ML Signal

HOLD

Logo Valneva SE

VALN

Valneva SE

HOLD

Current Price

$6.16

Market Cap

536.9M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
LDP
VALN
Founded
2012
2012
Country
United States
France
Employees
N/A
N/A
Industry
Finance Companies
Biotechnology: Biological Products (No Diagnostic Substances)
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
606.3M
536.9M
IPO Year
N/A
2021

Fundamental Metrics

Financial Performance
Metric
LDP
VALN
Price
$20.70
$6.16
Analyst Decision
Strong Buy
Analyst Count
0
2
Target Price
N/A
$15.50
AVG Volume (30 Days)
66.2K
35.7K
Earning Date
01-01-0001
05-07-2026
Dividend Yield
7.91%
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
$93.87
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$19.35
$5.06
52 Week High
$22.05
$12.25

Technical Indicators

Market Signals
Indicator
LDP
VALN
Relative Strength Index (RSI) 53.47 55.45
Support Level $20.60 $5.68
Resistance Level $21.10 $6.53
Average True Range (ATR) 0.23 0.31
MACD 0.01 0.12
Stochastic Oscillator 59.43 58.21

Price Performance

Historical Comparison
LDP
VALN

About LDP Cohen & Steers Limited Duration Preferred and Income Fund Inc.

Cohen & Steers Ltd Duration Preferred & Income Fund, Inc. is a diversified closed-end management investment company. Its primary investment objective is high current income and capital appreciation is its secondary investment objective. The Fund invests at least its managed assets in preferred and other income securities issued by U.S. and non-U.S. companies under normal market conditions.

About VALN Valneva SE

Valneva SE is a vaccine company focused on developing life-saving vaccines. Its portfolio includes three vaccines for travelers. The segments of the group are Commercialized vaccines which relate to marketed vaccines, the group's vaccines IXIARO/JESPECT, DUKORAL, IXCHIQ; Covid includes development, manufacturing, & distribution related to the COVID-19 vaccine, Vaccine candidates which relate to research and development programs to generate new approvable products to generate future cash flows from product sales through partnering with pharmaceutical companies; & Technologies and services which relate to services and inventions at a commercialization stage. The company generates majority of its revenue from product sales.

Share on Social Networks: